Shareholder Information

Financial Calendar

POXEL (Euronext - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announces its schedule for the publication of financial information for 2017.

Event Date*
2016 Q4 Financial Update January 27, 2017
2016 Full Year Financial Statement April 3, 2017
2017 Q1 Financial Update May 4, 2017
2017 Q2 Financial Update July 10, 2017
2017 First Half Financial Statement September 21, 2017
2017 Q3 Financial Update October 16, 2017
2017 Q4 Financial Update January 22, 2018

*Subject to modification.

Financial Press Releases

2017

2016

2015

Regulatory Documentation

2017

2016

2015

IPO February 2015

Webcast

Annual General Meeting 2017

Documents regarding the Annual General Meeting on June 30, 2017:

General Meetings 2016

Documents regarding the Second General Meeting on June 30, 2016:

Documents regarding the First General Meeting on January 29, 2016:

Annual General Meeting 2015

Documents regarding the Annual General Meeting on June 16, 2015:

Structure